Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials

Abstract Background Heterogeneous treatment effects (HTEs), or systematic differences in treatment effectiveness among participants with different observable features, may be important when applying trial results to clinical practice. Current methods suffer from a potential for false detection of HT...

Full description

Bibliographic Details
Main Authors: Joseph Rigdon, Michael Baiocchi, Sanjay Basu
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-018-2774-5
id doaj-bb257b64785245808d6186ce9f9adcce
record_format Article
spelling doaj-bb257b64785245808d6186ce9f9adcce2020-11-24T21:04:43ZengBMCTrials1745-62152018-07-0119111510.1186/s13063-018-2774-5Preventing false discovery of heterogeneous treatment effect subgroups in randomized trialsJoseph Rigdon0Michael Baiocchi1Sanjay Basu2Quantitative Sciences Unit, Stanford University School of MedicineStanford Prevention Research Center, Stanford University School of MedicineDepartments of Medicine and of Health Research and Policy, Center for Primary Care and Outcomes Research and Center for Population Health Sciences, Stanford University School of MedicineAbstract Background Heterogeneous treatment effects (HTEs), or systematic differences in treatment effectiveness among participants with different observable features, may be important when applying trial results to clinical practice. Current methods suffer from a potential for false detection of HTEs due to imbalances in covariates between candidate subgroups. Methods We introduce a new method, matching plus classification and regression trees (mCART), that yields balance in covariates in identified HTE subgroups. We compared mCART to a classical method (logistic regression [LR] with backwards covariate selection using the Akaike information criterion ) and two machine-learning approaches increasingly applied to HTE detection (random forest [RF] and gradient RF) in simulations with a binary outcome with known HTE subgroups. We considered an N = 200 phase II oncology trial where there were either no HTEs (1A) or two HTE subgroups (1B) and an N = 6000 phase III cardiovascular disease trial where there were either no HTEs (2A) or four HTE subgroups (2B). Additionally, we considered an N = 6000 phase III cardiovascular disease trial where there was no average treatment effect but there were four HTE subgroups (2C). Results In simulations 1A and 2A (no HTEs), mCART did not identify any HTE subgroups, whereas LR found 2 and 448, RF 5 and 2, and gradient RF 5 and 24, respectively (all false positives). In simulation 1B, mCART failed to identify the two true HTE subgroups whereas LR found 4, RF 6, and gradient RF 10 (half or more of which were false positives). In simulations 2B and 2C, mCART captured the four true HTE subgroups, whereas the other methods found only false positives. All HTE subgroups identified by mCART had acceptable treated vs. control covariate balance with absolute standardized differences less than 0.2, whereas the absolute standardized differences for the other methods typically exceeded 0.2. The imbalance in covariates in identified subgroups for LR, RF, and gradient RF indicates the false HTE detection may have been due to confounding. Conclusions Covariate imbalances may be producing false positives in subgroup analyses. mCART could be a useful tool to help prevent the false discovery of HTE subgroups in secondary analyses of randomized trial data.http://link.springer.com/article/10.1186/s13063-018-2774-5Classification and regression treesDecision support toolHeterogeneous treatment effectsMatching
collection DOAJ
language English
format Article
sources DOAJ
author Joseph Rigdon
Michael Baiocchi
Sanjay Basu
spellingShingle Joseph Rigdon
Michael Baiocchi
Sanjay Basu
Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
Trials
Classification and regression trees
Decision support tool
Heterogeneous treatment effects
Matching
author_facet Joseph Rigdon
Michael Baiocchi
Sanjay Basu
author_sort Joseph Rigdon
title Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
title_short Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
title_full Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
title_fullStr Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
title_full_unstemmed Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
title_sort preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
publisher BMC
series Trials
issn 1745-6215
publishDate 2018-07-01
description Abstract Background Heterogeneous treatment effects (HTEs), or systematic differences in treatment effectiveness among participants with different observable features, may be important when applying trial results to clinical practice. Current methods suffer from a potential for false detection of HTEs due to imbalances in covariates between candidate subgroups. Methods We introduce a new method, matching plus classification and regression trees (mCART), that yields balance in covariates in identified HTE subgroups. We compared mCART to a classical method (logistic regression [LR] with backwards covariate selection using the Akaike information criterion ) and two machine-learning approaches increasingly applied to HTE detection (random forest [RF] and gradient RF) in simulations with a binary outcome with known HTE subgroups. We considered an N = 200 phase II oncology trial where there were either no HTEs (1A) or two HTE subgroups (1B) and an N = 6000 phase III cardiovascular disease trial where there were either no HTEs (2A) or four HTE subgroups (2B). Additionally, we considered an N = 6000 phase III cardiovascular disease trial where there was no average treatment effect but there were four HTE subgroups (2C). Results In simulations 1A and 2A (no HTEs), mCART did not identify any HTE subgroups, whereas LR found 2 and 448, RF 5 and 2, and gradient RF 5 and 24, respectively (all false positives). In simulation 1B, mCART failed to identify the two true HTE subgroups whereas LR found 4, RF 6, and gradient RF 10 (half or more of which were false positives). In simulations 2B and 2C, mCART captured the four true HTE subgroups, whereas the other methods found only false positives. All HTE subgroups identified by mCART had acceptable treated vs. control covariate balance with absolute standardized differences less than 0.2, whereas the absolute standardized differences for the other methods typically exceeded 0.2. The imbalance in covariates in identified subgroups for LR, RF, and gradient RF indicates the false HTE detection may have been due to confounding. Conclusions Covariate imbalances may be producing false positives in subgroup analyses. mCART could be a useful tool to help prevent the false discovery of HTE subgroups in secondary analyses of randomized trial data.
topic Classification and regression trees
Decision support tool
Heterogeneous treatment effects
Matching
url http://link.springer.com/article/10.1186/s13063-018-2774-5
work_keys_str_mv AT josephrigdon preventingfalsediscoveryofheterogeneoustreatmenteffectsubgroupsinrandomizedtrials
AT michaelbaiocchi preventingfalsediscoveryofheterogeneoustreatmenteffectsubgroupsinrandomizedtrials
AT sanjaybasu preventingfalsediscoveryofheterogeneoustreatmenteffectsubgroupsinrandomizedtrials
_version_ 1716770030355480576